The reiteration of a Buy rating by Stifel analyst Paul Matteis indicates a positive outlook for PepGen's stock. The maintained $24 price target suggests that the analyst believes the stock has potential for growth in the short term. This news is highly relevant and important for investors in PepGen, as it provides a professional opinion on the stock's potential performance.